Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Q4 2022 Zydus Lifesciences Ltd Earnings Call Transcript

May 20, 2022 / 11:00AM GMT
Release Date Price: ₹357.15 (+5.48%)
Operator

Ladies and gentlemen, good day, and welcome to the Zydus Lifesciences Limited Quarter 4 FY '22 Post Results Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Ganesh Nayak, Executive Director, Zydus Lifesciences Limited. Thank you, and over to you, sir.

Ganesh Narayan Nayak
Zydus Lifesciences Limited - COO & Executive Director

Thank you. Good evening, ladies and gentlemen. Welcome to our post results teleconference for the quarter and year ended March 31, 2022.

For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Arvind Bothra, Senior Vice President, Investor Relations; and Mr. Alok Garg, Senior Vice President from the Managing Directors' Office.

I hope you would have gone through the quarterly results investor presentation, which we have posted on our website and filed with the stock exchanges. I'm pleased to share our performance for the financial year '21, '22 as we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot